Hosted on MSN21m
Altimmune, Inc. (NASDAQ:ALT) Q3 2024 Earnings Call TranscriptPemvidutide has the potential to be the first incretin agent to achieve statistical significance in MASH ... indications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback